Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06031272
What this trial is testing

Pausing Antiretroviral Treatment Under Structured Evaluation

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 32
Post-approval studies (Phase 4)UnknownNCT01768195
What this trial is testing

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

Who this might be right for
Hepatitis B
Peking University 80
Testing effectiveness (Phase 2)Study completedNCT01020565
What this trial is testing

A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 60
Testing effectiveness (Phase 2)Ended earlyNCT02927431
What this trial is testing

Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza

Who this might be right for
Virus Diseases
GlaxoSmithKline 10
Post-approval studies (Phase 4)Looking for participantsNCT07189377
What this trial is testing

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Who this might be right for
Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT00851890
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 30
Early research (Phase 1)Study completedNCT01950325
What this trial is testing

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

Who this might be right for
HIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Testing effectiveness (Phase 2)Study completedNCT00270010
What this trial is testing

Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

Who this might be right for
AnemiaAcquired Immunodeficiency Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 72
Not applicableStudy completedNCT02782247
What this trial is testing

Dynamic Liver Tests in Liver Disease

Who this might be right for
Hepatitis BHepatitis C
Queen Mary University of London 52
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Early research (Phase 1)Study completedNCT00971308
What this trial is testing

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 37
Large-scale testing (Phase 3)Study completedNCT01604850
What this trial is testing

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 202
Very early researchUnknownNCT03882307
What this trial is testing

Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

Who this might be right for
Hepatitis C, Chronic
Assiut University 40
Testing effectiveness (Phase 2)Study completedNCT00016718
What this trial is testing

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 43
Testing effectiveness (Phase 2)Study completedNCT02254408
What this trial is testing

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus
Gilead Sciences 189
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Testing effectiveness (Phase 2)Study completedNCT00000791
What this trial is testing

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 210
Testing effectiveness (Phase 2)Study completedNCT00118768
What this trial is testing

Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 175
Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Next Page